Journal Mobile Options
Table of Contents
Vol. 21, No. 3, 2006
Issue release date: February 2006
Cerebrovasc Dis 2006;21:180–186
(DOI:10.1159/000090530)

Cerebrovascular Reactivity to L-Arginine in Patients with Lacunar Infarctions

Pretnar-Oblak J. · Zaletel M. · Zvan B. · Sabovic M. · Pogacnik T.
Departments of a Neurology and b Internal Medicine, Ljubljana Medical Centre, Ljubljana, Slovenia

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Background: It is well known that endothelial dysfunction plays an important role in the pathogenesis of many cardiovascular disorders. The aim of this study was to test the hypothesis that specific, marked endothelial dysfunction of cerebral arteries is present in patients with lacunar cerebral infarctions. Methods: Cerebrovascular reactivity to L-arginine, which reveals the function of the cerebral endothelium, was investigated in patients with lacunar infarctions (20 patients, 11 male and 9 female, aged 60.9 ± 7.3 years), 21 age- and gender-matched asymptomatic patients with similar cardiovascular risk factors (all patients had arterial hypertension) and 21 age- and gender-matched healthy controls. The mean arterial velocity (vm) in both middle cerebral arteries was measured by transcranial Doppler sonography during a 15-min baseline period, a 30-min intravenous infusion of L-arginine and a 15-min interval after L-arginine infusion. Arterial blood pressure, heart rate and CO2 were measured continuously. Results: The measured vm increase during L-arginine infusion in the patients with lacunar infarctions (13.4 ± 9.1%) was significantly lower compared to the healthy controls (20.5 ± 9.9%) but similar to that obtained in the patients with cardiovascular risk factors (11.5 ± 8.9%). Conclusions: Our results showed that cerebrovascular reactivity to L-arginine, which demonstrates cerebral endothelial function, is significantly impaired in patients with cardiovascular risk factors. Importantly, we found that patients with lacunar infarctions do not show any additional impairment of cerebral endothelial function.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Kolominsky-Rabas PL, Weber M, Gefeller O, Neundoerfer B, Heuschmann PU: Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study. Stroke 2001;32:2735–2740.
  2. Hassan A, Hunt BJ, O’Sullivan M, Bell R, D’Souza R, Jeffery S, Bamford JM, Markus HS: Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction. Brain 2004;127:212–219.
  3. Boiten J, Lodder J: Risk factors for lacunar infarction; in Donnan G, Norrving B, Bamford J, Bogousslavsky J (eds): Lacunar and Other Subcortical Infarctions. Oxford, Oxford University Press, 1995, pp 56–69.
  4. Rosenblum WI, Nishimura H, Nelson GH: Endothelial dependant L-A and L-NMMA-sensitive mechanisms regulate tone of brain microvessels. Am J Physiol 1990;259:H1395– H1401.
  5. Micieli G, Bosone D, Costa A, Cavallini A, Marcheselli S, Pompeo F, Nappi G: Opposite effects of l-arginine and nitroglycerin on cerebral blood velocity: nitric oxide precursors and cerebral blood velocity. J Neurol Sci 1997;150:71–75.
  6. Micieli G, Bosone D, Zappoli F, Marcheselli S, Argenteri A, Nappi G: Vasomotor response to CO2 and L-arginine in patients with severe internal carotid artery stenosis: pre- and post-surgical evaluation with transcranial Doppler. J Neurol Sci 1999;163:153–158.
  7. Okamoto M, Etani H, Yagita Y, Kinoshita N, Nukada T: Diminished reserve for cerebral vasomotor response to l-arginine in the elderly: evaluation by transcranial Doppler sonography. Gerontology 2001;47:131–135.
  8. Zimmermann C, Wimmer M, Haberl RL: L-Arginine-mediated vasoreactivity in patients with risk of stroke. Cerebrovasc Dis 2004;17:128–133.
  9. Zvan B, Zaletel M, Pogacnik T, Kiauta T: Testing of cerebral endothelium function with l-arginine after stroke. Int Angiol 2002;21:256–259.
  10. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE: Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22–27.
  11. Linder L, Kiowski W, Buhler FR, Luscher TF: Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo: blunted response in essential hypertension. Circulation 1990;81:1762–1767.
  12. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Desvarieux M, Ebrahim S, Fatar M, Hernandez Hernandez R, Kownator S, Prati P, Rundek T, Taylor A, Bornstein N, Csiba L, Vicaut E, Woo KS, Zannad F: Mannheim intima-media thickness consensus on behalf of the Advisory Board of the 3rd Watching the Risk Symposium 2004. 13th European Stroke Conference, Mannheim, Germany, May 14, 2004. Cerebrovasc Dis 2004;18:346–349.
  13. de Bray JM, Baud JM, Delanoy P, Camuzat JP, Dehans V, Descamp-Le Chevoir J, Launay JR, Luizy F, Sentou Y, Cales P: Reproducibility in ultrasonic characterization of carotid plaques. Cerebrovasc Dis 1998;8:273–277.
  14. Grant EG, Benson CB, Moneta GL, Alexandrov AV, Baker JD, Bluth EI, Carroll BA, Eliasziw M, Gocke J, Hertzberg BS, Katarick S, Needleman L, Pellerito J, Polak JF, Rholl KS, Wooster DL, Zierler E, Society of Radiologists in Ultrasound Carotid artery stenosis: Grayscale and Doppler ultrasound diagnosis – Society of Radiologists in Ultrasound consensus conference. Ultrasound Q 2003;19:190–198.
  15. Tousoulis D, Davies GJ, Tentolouris C, Crake T, Katsimaglis G, Stefanadis C, Toutouzas P: Effects of changing the availability of the substrate for nitric oxide synthase by L-arginine administration on coronary vasomotor tone in angina patients with angiographically narrowed and in patients with normal coronary arteries. Am J Cardiol 1998;82:1110–1113.
  16. Puddu P, Puddu GM, Zaca F, Muscari A: Endothelial dysfunction in hypertension. Acta Cardiol 2000;55:221–232.
  17. Tentolouris C, Tousoulis D, Goumas G, Stefanadis C, Davies G, Toutouzas P: L-Arginine in coronary atherosclerosis. Int J Cardiol 2000;75:123–128.
  18. Palmer RM, Ashton DS, Monchada S: Vascular endothelial cells synthesize nitric oxide from l-arginine. Nature 1988;333:664–666.
  19. Bruckdorfer R: The basics about nitric oxide. Mol Aspects Med 2005;26:3–31.
  20. Cooke JP, Dzau VJ: Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 1997;48:489–509.
  21. Samdani AF, Dawson TM, Dawson VL: Nitric oxide synthase in models of focal ischemia. Stroke 1997;28:1283–1288.
  22. Veltkamp R, Rajapakse N, Robins G, Puskar M, Shimizu K, Busija D: Transient focal ischemia increases endothelial nitric oxide synthase in cerebral blood vessels. Stroke 2002;33:2704–2710.
  23. Iadecola C: Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci 1997;20:132–139.
  24. Kario K, Matsuo T, Kobayashi H, Hoshide S, Shimada K: Hyperinsulinemia and hemostatic abnormalities are associated with silent lacunar cerebral infarcts in elderly hypertensive subjects. J Am Coll Cardiol 2001;37:871–877.
  25. Carmelli D, De Carli C, Swan GE, Jack LM, Reed T, Wolf PA, Miller BL: Evidence for genetic variance in white matter hyperintensity volume in normal elderly male twins. Stroke 1998;29:1177–1181.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50